Treatment of uncomplicated falciparum malaria in Bobo-Dioulasso, Burkina Faso: comparison of amodiaquine sulfadoxine-pyrimethamine with Coartem

Completed

• Conditions: Malaria; Infections and Infestations

• Registration Number: ISRCTN54261005
• Lead Sponsor: Institute of Research in Health Sciences (Institut de Recherches en Sciences de la Sante [IRSS]) (Burkina Faso)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-05-05
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 521

Inclusion Criteria

1. Age =6 months
2. Fever (=37.5 or history of fever in the last 24 hours)
3. Provision of informed consent
4. P. falciparum mono infection
5. Parasite density >2000 microliters and =200,000 microliters

Exclusion Criteria

1. Evidence of severe malaria
2. History of side effects to the investigational product
3. Pregnancy
4. Repeated vomiting of study medication on day 0
5. Hemoglobin <5 g/Dl
6. Evidence of concomitant febrile illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified